Ekso Bionics Holdings Inc Share Price Deutsche Boerse AG
Equities
US2826441030
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- EUR | - |
|
25/06 | Ekso Bionics Announces Research Partnership with Shepherd Center | CI |
24/06 | Lake Street Starts Coverage on Ekso Bionics With Buy Rating, $2.50 Price Target | MT |
Sales 2024 * | 2.05Cr 1.88Cr 171.46Cr | Sales 2025 * | 2.81Cr 2.58Cr 234.8Cr | Capitalization | 2.49Cr 2.28Cr 208.02Cr |
---|---|---|---|---|---|
Net income 2024 * | -90L -82.59L -75Cr | Net income 2025 * | -40L -36.71L -33Cr | EV / Sales 2024 * | 1.21 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 0.89 x |
P/E ratio 2024 * |
-2.66
x | P/E ratio 2025 * |
-5.71
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.79% |
Latest transcript on Ekso Bionics Holdings Inc
Managers | Title | Age | Since |
---|---|---|---|
Scott Davis
CEO | Chief Executive Officer | 54 | 01/21/01 |
Jerome Wong
DFI | Director of Finance/CFO | 50 | 01/17/01 |
Jason Jones
COO | Chief Operating Officer | 52 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Corinna Lathan
BRD | Director/Board Member | 56 | 25/21/25 |
Mary Cloyd
BRD | Director/Board Member | 69 | 29/20/29 |
Charles Li
BRD | Director/Board Member | 39 | 11/18/11 |
1st Jan change | Capi. | |
---|---|---|
+2.62% | 21TCr | |
+6.44% | 18TCr | |
+29.61% | 16TCr | |
+34.96% | 11TCr | |
+2.85% | 6.65TCr | |
+17.38% | 5.39TCr | |
-4.51% | 4.63TCr | |
-5.77% | 3.82TCr | |
+3.71% | 3.66TCr |